CA
BBH icon

Cetera Advisors’s VanEck Biotech ETF BBH Stock Holding History

Cetera Advisors’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-50
Closed -$6K – 952
2019
Q1 		$6K Buy
+50
New +$6.32K ﹤0.01% 1165

Other funds holding BBH

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TIA
Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return
BRM
Boston Research & Management Manchester, Massachusetts $421M AUM 16.18% 1-Year Est. Return

Cetera Advisors's BBH Position: Q2 2019 in Review

Cetera Advisors sold out of VanEck Biotech ETF (BBH) in Q2 2019, closing a stake of 50 shares — an estimated $6K sold.

Cetera Advisors first reported a position in BBH in Q1 2019 and held it in 1 quarter. The position peaked at $6K in Q1 2019. 84 funds tracked by Wall St. Rank hold BBH as of Q2 2019.

  • Cetera Advisors reported no remaining VanEck Biotech ETF position as of Q2 2019 after selling out during the quarter.
  • Cetera Advisors sold 50 VanEck Biotech ETF shares in Q2 2019, an estimated $6K.
  • Cetera Advisors first reported a position in VanEck Biotech ETF in Q1 2019 and held it in 1 quarter.
  • Cetera Advisors's VanEck Biotech ETF position peaked at $6K in Q1 2019.
  • 84 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2019.

Based on Cetera Advisors's 13F filing for Q2 2019, filed 12 Aug 2019.